- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
EU drug regulator starts medical investigation of HPV vaccines
To review the link of HPV vaccines dosage to the complex regional pain syndrome, and POTS, but still recommends no changes in the shots of the medicine to treat cervical and womb cancer
The European medicine agency is a bit wary of cervical cancer vaccine (HPV Vaccine) links to two rare conditions of complex regional pain syndrome, CRPS (chronic pain condition affecting the limbs) and POTS, a condition where the heart rate jumps abnormally after sitting or standing. However, the agency has not yet emphasized to cautiously use the vaccines against the HPV, which is currently used to treat over 70 million of cancer patients worldwide.
The European agency said it is not recommending any changes in the use of the vaccine while the review is being conducted and that the review "does not question that the benefits of HPV vaccines outweigh their risks."
Current HPV vaccines information doesn't include warnings about these conditions and no causal link has been found.
Cervical cancer is said to be the leading cause of cancer deaths among women in India, with approximately 1.32 lakh new cases of cervical cancer being diagnosed and about 74,000 deaths occurring annually, accounting for nearly one-third of cervical cancer deaths across the world. It is primarily cause by HPV virus and is easily preventable by HPV vaccines.
The European medicine agency is a bit wary of cervical cancer vaccine (HPV Vaccine) links to two rare conditions of complex regional pain syndrome, CRPS (chronic pain condition affecting the limbs) and POTS, a condition where the heart rate jumps abnormally after sitting or standing. However, the agency has not yet emphasized to cautiously use the vaccines against the HPV, which is currently used to treat over 70 million of cancer patients worldwide.
The European agency said it is not recommending any changes in the use of the vaccine while the review is being conducted and that the review "does not question that the benefits of HPV vaccines outweigh their risks."
Current HPV vaccines information doesn't include warnings about these conditions and no causal link has been found.
Cervical cancer is said to be the leading cause of cancer deaths among women in India, with approximately 1.32 lakh new cases of cervical cancer being diagnosed and about 74,000 deaths occurring annually, accounting for nearly one-third of cervical cancer deaths across the world. It is primarily cause by HPV virus and is easily preventable by HPV vaccines.
Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She is a member of the Association of Healthcare Journalists. She can be contacted at meghna@medicaldialogues.in. Contact no. 011-43720751
Next Story